Veracyte to Acquire HalioDx, Solidifying Global Leadership in Cancer Diagnostics     Learn More
Veracyte to Acquire HalioDx, Solidifying Global Leadership in Cancer Diagnostics     Learn More
Skip to content
4/A

SEC Filing Details

Document Details

Form
Filing Date
May 5, 2021
Document Date
Feb 25, 2021
Form Description
Amendment to a previously filed 4
Filing Group
3,4,5
Company
Veracyte, Inc.
Issuer
VERACYTE, INC.
Filer
EASTHAM KARIN